Immuneering (IMRX) Net Margin Growth (1y) (2021 - 2022)

Immuneering (IMRX) Net Margin Growth (1y) (2021 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immuneering 283.85 Mn 283.85 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -298.29 Mn
Sep 30, 2022 -8.78 Mn
Jun 30, 2022 -1.76 Mn
Mar 31, 2022 -900,728.00
Dec 31, 2021 -492,119.00
Sep 30, 2021 -1.28 Mn
Jun 30, 2021 -221,025.00